Merck ends development of Covid drug it acquired from OncoImmune
April 15, 2021 at 06:46 AM EDT
Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|